Seppenwoolde Yvette, De Jaeger Katrien, Boersma Liesbeth J, Belderbos José S A, Lebesque Joos V
Department of Radiotherapy, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.
Int J Radiat Oncol Biol Phys. 2004 Nov 1;60(3):748-58. doi: 10.1016/j.ijrobp.2004.04.037.
To study regional differences in lung radiosensitivity by evaluating the incidence of radiation pneumonitis (RP) in relation to regional dose distributions.
Registered chest CT and single photon emission CT lung perfusion scans were obtained in 106 patients before curative or radical radiotherapy for non-small-cell lung cancer. The mean lung dose (MLD) was calculated. The single photon-emission CT perfusion data were used to weigh the MLD with perfusion, resulting in the mean perfusion-weighted lung dose. In addition, the lungs were geometrically divided into different subvolumes. The mean regional dose (MRD) for each region was calculated and weighted with the perfusion of each region to obtain the mean perfusion-weighted regional dose. RP was defined as respiratory symptoms requiring steroids. The incidence of RP for patients with tumors in a specific subvolume was calculated. The normal tissue complication probability (NTCP) parameter values for the TD(50), and an offset NTCP parameter for tumor location were fitted for both lungs and for each lung subvolume to the observed data using maximum likelihood analysis.
The incidence of RP correlated significantly with the MLD and MRD of the posterior, caudal, ipsilateral, central, and peripheral lung subvolumes (p between 0.05 and 0.002); no correlation was seen for the anterior, cranial, and contralateral regions Similarly, a statistically significant correlation was observed between the incidence of RP and the perfusion-weighted MLD and perfusion-weighted MRD for all regions, except the anterior lung region. For this region, the dose-effect relation improved remarkably after weighting the local dose with the local perfusion. A statistically significant difference (p = 0.01) in the incidence of RP was found between patients with cranial and caudal tumors (11% and 40%, respectively). Therefore, a dose-independent offset NTCP parameter for caudal tumors was included in the NTCP model, improving most correlations significantly, confirming that patients with caudal tumors have a greater probability of developing RP.
The incidence of RP correlated significantly with the MLD and MRD of most lung regions, except for the anterior, cranial, and contralateral regions. Weighting the local dose with the local perfusion improved the dose-effect relation for the anterior lung region. Irradiation of caudally located lung tumors resulted in a greater risk of RP than irradiation of tumors located in other parts of the lungs.
通过评估放射性肺炎(RP)的发生率与区域剂量分布的关系,研究肺放射性敏感性的区域差异。
对106例接受非小细胞肺癌根治性或姑息性放疗的患者,在放疗前进行胸部CT和单光子发射CT肺灌注扫描。计算平均肺剂量(MLD)。利用单光子发射CT灌注数据对MLD进行灌注加权,得到平均灌注加权肺剂量。此外,将肺在几何上划分为不同的子体积。计算每个区域的平均区域剂量(MRD),并对每个区域的灌注进行加权,以获得平均灌注加权区域剂量。RP定义为需要使用类固醇治疗的呼吸道症状。计算特定子体积内肿瘤患者的RP发生率。使用最大似然分析,将TD(50)的正常组织并发症概率(NTCP)参数值以及肿瘤位置的偏移NTCP参数,针对双侧肺和每个肺子体积拟合到观察数据中。
RP的发生率与后、尾、同侧、中央和外周肺子体积的MLD和MRD显著相关(p值在0.05至0.002之间);前、头和对侧区域未见相关性。同样,除前肺区域外,所有区域的RP发生率与灌注加权MLD和灌注加权MRD之间均观察到统计学显著相关性。对于该区域,用局部灌注对局部剂量进行加权后,剂量-效应关系显著改善。头侧和尾侧肿瘤患者的RP发生率存在统计学显著差异(p = 0.01)(分别为11%和40%)。因此,NTCP模型中纳入了尾侧肿瘤的剂量独立偏移NTCP参数,显著改善了大多数相关性,证实尾侧肿瘤患者发生RP的可能性更大。
RP的发生率与大多数肺区域的MLD和MRD显著相关,前、头和对侧区域除外。用局部灌注对局部剂量进行加权改善了前肺区域的剂量-效应关系。照射位于肺尾侧的肿瘤比照射位于肺其他部位的肿瘤导致RP的风险更大。